Drug to prevent RSV in babies approved: What you need to know
The Food and Drug Administration (FDA) approved a drug to help protect infants from respiratory syncytial virus (RSV). The medication, given as a single-dose injection prior to or during RSV season, is a monoclonal antibody. It is intended for babies born during or entering their first RSV season and for…
Tribune News Service ·